Cargando…

A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy

Dramatic improvements in cancer survival have occurred in the last decade, but the quality of life for many survivors is compromised due to severe, long-lasting, and often irreversible side effects of chemotherapy. The neurological side effects, chemotherapy induced peripheral neuropathy (CIPN) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Eiman Y., Munshani, Saira, Domenicano, Ilaria, Rodwin, Rozalyn, Nowak, Richard J., Pusztai, Lajos, Lustberg, Maryam, Ehrlich, Barbara E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543876/ https://www.ncbi.nlm.nih.gov/pubmed/36206298 http://dx.doi.org/10.1371/journal.pone.0275648

Ejemplares similares

The Impact of Mutations in Wolframin on Psychiatric Disorders
por: Munshani, Saira, et al.
Publicado: (2021)

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
por: Rodwin, Rozalyn L., et al.
Publicado: (2022)

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
por: Ibrahim, Eiman Y., et al.
Publicado: (2021)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
por: Li, Yang, et al.
Publicado: (2021)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
por: Schneider, Bryan P., et al.
Publicado: (2016)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
por: Bandla, Aishwarya, et al.
Publicado: (2019)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
por: Sharma, Anukriti, et al.
Publicado: (2022)

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
por: Mo, Hongnan, et al.
Publicado: (2022)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy
por: Chan, Alexandre, et al.
Publicado: (2022)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018)

Cold Application and Exercise on Development of Peripheral Neuropathy during Taxane Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial
por: Şimşek, Neriman Yükseltürk, et al.
Publicado: (2021)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
por: Dorand, R. Dixon, et al.
Publicado: (2023)

Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer
por: Verhoeff-Jahja, Rita, et al.
Publicado: (2022)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Novel Functional Assay for Spindle-Assembly Checkpoint by Cyclin-Dependent Kinase Activity to Predict Taxane Chemosensitivity in Breast Tumor Patient
por: Torikoshi, Yasuhiro, et al.
Publicado: (2013)

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
por: Pfeiffer, Per, et al.
Publicado: (2022)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
por: Knoerl, Robert, et al.
Publicado: (2021)

Taxane-Induced Upper Gastrointestinal Bleeding
por: Liu, Yao, et al.
Publicado: (2021)

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
por: Zhai, Jingtong, et al.
Publicado: (2022)

GAIT UNSTEADINESS AS AN INDICATOR OF COGNITIVE STATUS IN INDIVIDUALS WITH PERIPHERAL NEUROPATHY
por: Kang, Gu Eon, et al.
Publicado: (2019)

Relationship between peripheral neuropathy and cognitive performance in the elderly population
por: Lin, Yu-Jen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49n529a87s7etq9aijkohiahdr